Comparator: montelukast

DRUG8 trials

Sponsors

Organon and Co, Merck Sharp & Dohme LLC

Conditions

AsthmaAsthma, Exercise-InducedChronic AsthmaSeasonal Allergic Rhinitis

Phase 1

The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

CompletedNCT00739297

Organon and CoChronic Asthma

Start: 2008-07-31End: 2008-12-31Updated: 2024-05-09

Early Airway Response to Allergen in Asthmatics (MK-0000-176)

CompletedNCT01061333

Merck Sharp & Dohme LLCAsthma

Start: 2010-06-30End: 2011-03-31Updated: 2015-09-04

Phase 2

Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)

CompletedNCT00666679

Organon and CoAsthma

Start: 2008-05-31End: 2009-02-28Updated: 2024-05-10

Phase 3

Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)

CompletedNCT00090142

Organon and CoAsthma, Exercise-Induced

Start: 2004-05-31End: 2004-10-31Updated: 2022-02-02

Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)

CompletedNCT00092131

Organon and CoAsthma, Exercise-Induced

Start: 2003-06-30End: 2003-11-30Updated: 2022-02-02

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

CompletedNCT00245570

Organon and CoAsthma, Exercise-Induced

Start: 2005-12-31End: 2006-09-30Updated: 2022-02-02

Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)

CompletedNCT00963599

Organon and CoSeasonal Allergic Rhinitis

Start: 1999-09-30End: 1999-11-30Updated: 2022-02-09

Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

CompletedNCT00979901

Organon and CoSeasonal Allergic Rhinitis

Start: 2000-03-31End: 2000-05-31Updated: 2022-02-09